Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00809224 · ClinicalTrials.gov registry record
Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 92
- Enrollment target
NCT00809224 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 92 participants.
The verdict
NCT00809224 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
Study Summary
The purpose of this study is to track areas of the brain, via functional magnetic resonance imaging (fMRI), that retain structural and functional integrity throughout the lifespan of people with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00809224
The ClinicalTrials.gov registry entry for NCT00809224 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00809224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00809224 about?
NCT00809224 is a clinical study titled "Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)". The purpose of this study is to track areas of the brain, via functional magnetic resonance imaging (fMRI), that retain structural and functional integrity throughout the lifespan of people with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
What is the current status of trial NCT00809224?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2008-05. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT00809224?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.